News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
163 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37187)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (27455)
Month
January (2434)
February (2867)
March (3030)
April (3117)
May (3356)
June (2726)
July (2287)
August (2491)
September (2814)
October (2333)
Day
1 (180)
2 (176)
3 (166)
4 (36)
6 (28)
7 (20)
8 (209)
9 (212)
10 (153)
11 (45)
13 (31)
14 (133)
15 (141)
16 (97)
17 (129)
18 (39)
20 (21)
21 (93)
22 (125)
23 (160)
24 (113)
25 (42)
27 (22)
28 (135)
29 (163)
30 (145)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
27
28
29
30
Press Releases
iRegene Therapeutics’s NouvSight001 Cleared for Clinical Trials in the U.S. and China for Retinitis Pigmentosa
September 29, 2026
·
5 min read
Press Releases
Lilly’s Foundayo (orforglipron) 17.2 mg showed greater weight loss and A1C reduction than oral semaglutide 25 mg among adults with type 2 diabetes in a new indirect treatment comparison
September 29, 2026
·
21 min read
Press Releases
Breye Therapeutics raises €67.5 million in over-subscribed Series A financing
September 29, 2026
·
5 min read
Press Releases
Kither Biotech Initiates Dosing of Patients in Phase 1b / 2a Study of KIT2014 in COPD
September 29, 2026
·
6 min read
Press Releases
Vetter expands global manufacturing network to support future customer needs
Strategic investments strengthen resilience and service capabilities for innovative injectable therapies · First of ten additional commercial manufacturing lines already operational · Continued expansion of global filling capabilities · Ongoing investments strengthen flexibility, resilience, and supply security
September 29, 2026
·
1 min read
Press Releases
Cyprumed‘s Oral Delivery Technology Advances to Clinical Stage as MSD Initiates Phase I Trial
September 29, 2026
·
2 min read
Press Releases
2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma
September 29, 2026
·
10 min read
Press Releases
Caspian Therapeutics Unveils KO-7246 at EASD as a Potential Best-In-Class Menin Inhibitor for Diabetes
September 29, 2026
·
8 min read
Press Releases
Landmark Medicines Advances Proprietary Nasal GLP-1 Platform Towards Human Evaluation
September 29, 2026
·
2 min read
Press Releases
Novo’s Ozempic® (semaglutide) 2 mg associated with lower risk of major adverse cardiovascular events (death, heart attack, and stroke) in adults with type 2 diabetes compared to switching to Mounjaro® (tirzepatide), in real-world analysis at EASD
September 29, 2026
·
6 min read
Previous
2 of 17
Next
